Patents by Inventor Na-ra Lee

Na-ra Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
    Patent number: 12637410
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse/addiction and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: May 26, 2026
    Assignee: University of Kentucky Research Foundation
    Inventors: Linda P. Dwoskin, David Watt, Jon Thorson, Mark Leggas, Rodney Kip Guy, Jared Hammill, Stefan Kwiatkowski, Derong Ding, Guangrong Zheng, Peter Anthony Crooks, Na-Ra Lee
  • ANTIVIRAL COMPOSITION COMPRISING NUCLEOSIDE ANALOGUES DERIVED FROM NUCLEIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
    Publication number: 20250057849
    Abstract: The present application relates to an antiviral composition comprising nucleoside analogues derived from a nucleotide, and a composition, a feed or a feed additive for enhancing immunity.
    Type: Application
    Filed: December 22, 2022
    Publication date: February 20, 2025
    Applicant: CJ CheilJedang Corporation
    Inventors: Ho Jin MOON, Young Nam KIM, Na-Ra LEE, Changsuk LEE, Ah Reum CHO
  • Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
    Patent number: 11999676
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Grant
    Filed: April 14, 2020
    Date of Patent: June 4, 2024
    Assignee: University of Kentucky Research Foundation
    Inventors: Linda P. Dwoskin, David Watt, Jon Thorson, Mark Leggas, Kip Guy, Jared Hammill, Stefan Kwiatkowski, Derong Ding, Guangrong Zheng, Peter Anthony Crooks, Na-Ra Lee
  • Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
    Publication number: 20220315523
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse/addiction and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Application
    Filed: June 16, 2022
    Publication date: October 6, 2022
    Inventors: Linda P. DWOSKIN, David WATT, Jon THORSON, Mark LEGGAS, Rodney Kip GUY, Jared HAMMILL, Stefan KWIATKOWSKI, Derong DING, Guangrong ZHENG, Peter Anthony CROOKS, Na-Ra LEE
  • Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
    Publication number: 20200290948
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Application
    Filed: April 14, 2020
    Publication date: September 17, 2020
    Inventors: Linda P. DWOSKIN, David WATT, Jon THORSON, Mark LEGGAS, Kip GUY, Jared HAMMILL, Stefan KWIATKOWSKI, Derong DING, Guangrong ZHENG, Peter Anthony CROOKS, Na-Ra LEE
  • VESICULAR MONOAMINE TRANSPORTER-2 LIGANDS AND THEIR USE IN THE TREATMENT OF PSYCHOSTIMULANT ABUSE
    Publication number: 20200237688
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Inventors: Linda P. DWOSKIN, Peter Anthony CROOKS, Guangrong ZHENG, Justin R. NICKELL, Zheng CAO, Na-Ra LEE
  • Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse
    Patent number: 10668030
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: June 2, 2020
    Assignee: University of Kentucky Research Foundation
    Inventors: Linda P. Dwoskin, Peter Anthony Crooks, Guangrong Zheng, Justin R. Nickell, Zheng Cao, Na-Ra Lee
  • Vesicular Monoamine Transporter-2 Ligands and Their Use in the Treatment of Psychostimulant Abuse
    Publication number: 20170304227
    Abstract: The present invention relates to methods of treatment of a disease or pathology of the central nervous system, an eating disorder, or substance use disorder, drug dependence/abuse and withdrawal therefrom comprising administering at least one N-phenylalkyl amphetamine derivative and pharmaceutical compositions comprising at least one N-phenylalkyl amphetamine derivative to an individual in need thereof.
    Type: Application
    Filed: April 21, 2017
    Publication date: October 26, 2017
    Inventors: Linda DWOSKIN, Peter Anthony CROOKS, Guangrong ZHENG, Justin R. NICKELL, Zheng CAO, Na-Ra LEE
  • Method for MNOnanoparticles by solid-state decomposition of exfoliated MNOnanosheet
    Patent number: 9133040
    Abstract: A method of preparing one-dimensional trimanganese tetroxide (Mn3O4) nanoparticles from an exfoliated two-dimensional manganese dioxide (MnO2) nanosheet using a solid-state decomposition method, and Mn3O4 nanoparticles prepared according to the method are provided. The Mn3O4 nanoparticles can be prepared at a very low temperature without using an organic solvent or a chemical additive, compared to conventional synthesis methods.
    Type: Grant
    Filed: May 22, 2012
    Date of Patent: September 15, 2015
    Assignee: Dongguk University Industry-Academic Cooperation Foundation
    Inventors: Hyun Jung, Na-ra Lee
  • Method for MN3O4 nanoparticles by solid-state decomposition of exfoliated MNO2 nanosheet
    Publication number: 20130108542
    Abstract: A method of preparing one-dimensional trimanganese tetroxide (Mn3O4) nanoparticles from an exfoliated two-dimensional manganese dioxide (MnO2) nanosheet using a solid-state decomposition method, and Mn3O4 nanoparticles prepared according to the method are provided. The Mn3O4 nanoparticles can be prepared at a very low temperature without using an organic solvent or a chemical additive, compared to conventional synthesis methods.
    Type: Application
    Filed: May 22, 2012
    Publication date: May 2, 2013
    Applicant: DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Hyun Jung, Na-ra Lee